inVentiv Health is tapping the loan market for an acquisition and refinancing. UBS and Bank of America lead the facility, which comprises a six-year, $50 million revolver; a seven-year, $330 million first-lien term loan and a seven-year, $20 million delayed-draw term loan. Pricing is LIBOR plus 1 3/4%
...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: subs@globalcapital.com
Corporate access
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.
